Frankfurt - Delayed Quote EUR
Hikma Pharmaceuticals PLC (H5P.F)
23.20
+0.40
+(1.75%)
At close: April 29 at 9:49:51 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
564,000
564,000
608,000
585,000
638,000
Investing Cash Flow
-381,000
-381,000
-333,000
-607,000
-238,000
Financing Cash Flow
-188,000
-188,000
-337,000
-58,000
-287,000
End Cash Position
188,000
188,000
205,000
270,000
426,000
Capital Expenditure
-235,000
-235,000
-204,000
-225,000
-229,000
Issuance of Capital Stock
-38,000
-38,000
--
--
--
Issuance of Debt
1,071,000
1,071,000
1,215,000
1,781,000
393,000
Repayment of Debt
-947,000
-947,000
-1,308,000
-1,325,000
-476,000
Repurchase of Capital Stock
--
--
--
-300,000
--
Free Cash Flow
329,000
329,000
404,000
360,000
409,000
12/31/2021 - 2/22/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade